Novo Nordisk Foundation Allocates DKK 479 Million for AI and Health Projects

Jun 30, 2025
The Novo Nordisk Foundation has awarded DKK 479 million to nine projects focusing on biomanufacturing, cardiometabolic diseases, and artificial intelligence.

The Novo Nordisk Foundation has awarded DKK 479 million to nine innovative projects as part of its 2025 Challenge Programme, announced in a press release. These projects aim to advance health and sustainability through global collaboration, involving researchers from Denmark, Sweden, The Netherlands, Belgium, Germany, Australia, and the USA.

The funded projects span four key themes: biomanufacturing, cardiometabolic diseases, infectious disease interactions, and artificial intelligence. Notably, the AI-focused initiatives include developing personalized cancer treatment methodologies, optimizing solar cell technology, and creating early warning systems for Arctic climate changes.

Each project receives up to DKK 60 million, with objectives such as improving gas fermentation processes to reduce CO2 emissions and exploring the links between infectious diseases and cardiometabolic conditions. The Challenge Programme, established in 2014, continues to foster significant research and innovation in addressing societal challenges.

We hope you enjoyed this article

Free newsletter

AI Funding Brief

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.